Larrègue M, Ziegler J E, Lauret P, Bonafe J, Lorette G, Titi A, Ramdenee P, Bressieux J M
Ann Dermatol Venereol. 1986;113(3):207-24.
Twenty-seven cases of linear morphoea are reported and compared with 218 cases collected from the literature. The various parameters studied, including clinical features and laboratory results, were identical in both series. The aetiology of linear morphoea is unknown, even though injuries or fever have been noted as triggering factors in 20 p. 100 of the cases. Linear morphoea is a childhood disease: it begins at the age of 7 or 8 and predominates in females (63 p. 100 of the cases). Its onset is marked by the abrupt occurrence of sclerosis in most cases, although a solitary morphoea or a trophic plaque may precede the disease proper. In our series, muscular or articular involvement appeared from the start in 40 p. 100 of the patients at the same time as the initial cutaneous lesions. The active stage lasts 3 years and sometimes longer. It is characterized by extension (37 p. 100) or both extension and multiplication (63 p. 100) of the initial lesions. Regional complications aggravate linear morphoea and are more frequent in patients whose lesions extend and multiply. Their incidence was lower among the published cases than in our series. Depending on the author, retractile myositis is present in 37 to 59 p. 100 of the cases, joint stiffness in 18 to 40 p. 100 and shortening of a limb in 10 to 22 p. 100. These complications often regress incompletely, leaving sequelae which persist in the steady state in 75 p. 100 of the patients. Antinuclear antibodies, present in 37 p. 100 of the cases, are either of the homogeneous or of the speckled type. Jablonska has met them more frequently (50 p. 100), and they were often of the speckled type. The significance of these antibodies in linear morphoea is unclear since they appear inconstantly and later than clinical signs. The skin lesions associated with linear morphoea show that the other forms of scleroderma--i.e. plaque morphoea, erythematous atrophic or dyschromic plaques and guttate scleroderma--belong to the same family. The same associations are found in frontoparietal "coup de sabre" scleroderma. The treatment of linear morphoea is not yet standardized. At the moment, the best and most regular results are obtained with systemic corticosteroids and local physiotherapy.
报告了27例线状硬皮病病例,并与从文献中收集的218例病例进行了比较。两个系列中研究的各种参数,包括临床特征和实验室结果,都是相同的。线状硬皮病的病因尚不清楚,尽管在20%的病例中已注意到损伤或发热为触发因素。线状硬皮病是一种儿童疾病:发病于7、8岁,女性居多(占病例的63%)。在大多数情况下,其发病以硬化的突然出现为标志,尽管在疾病真正发作之前可能先出现孤立性硬斑病或营养性斑块。在我们的系列中,40%的患者在最初皮肤病变出现的同时,一开始就出现肌肉或关节受累。活动期持续3年,有时更长。其特征为初始病变的扩展(37%)或扩展与增多同时存在(63%)。局部并发症会使线状硬皮病加重,在病变扩展和增多的患者中更常见。其发生率在已发表的病例中低于我们的系列。根据作者的不同,37%至59%的病例存在回缩性肌炎,18%至40%的病例有关节僵硬,10%至22%的病例有肢体缩短。这些并发症往往消退不完全,75%的患者会留下后遗症并在稳定期持续存在。37%的病例存在抗核抗体,其类型为均质型或斑点型。雅布隆斯卡发现它们更为常见(50%),且往往为斑点型。这些抗体在线状硬皮病中的意义尚不清楚,因为它们出现不恒定且晚于临床体征。与线状硬皮病相关的皮肤病变表明,硬皮病的其他形式——即斑块状硬皮病、红斑萎缩性或色素沉着异常斑块以及点滴状硬皮病——属于同一类别。在额顶叶“剑伤”硬皮病中也发现了相同的关联。线状硬皮病的治疗尚未标准化。目前,使用全身皮质类固醇和局部物理治疗可获得最佳且最规律的疗效。